A potential new drug target for the treatment of schizophrenia

被引:0
|
作者
机构
来源
Nature Clinical Practice Neurology | 2008年 / 4卷 / 11期
关键词
D O I
10.1038/ncpneuro0903
中图分类号
学科分类号
摘要
引用
收藏
页码:580 / 581
页数:1
相关论文
共 50 条
  • [2] MODULATION OF THE ENDOCANNABINOID SYSTEM AS A POTENTIAL NEW TARGET IN THE TREATMENT OF SCHIZOPHRENIA
    Leweke, F. Markus
    Hellmich, Martin
    Pahlisch, Franziska
    Kranaster, Laura
    Koethe, Dagmar
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S47 - S47
  • [3] Potential drug targets and treatment of schizophrenia
    Kumar, Anil
    Yadav, Monu
    Parle, Milind
    Dhingra, Sameer
    Dhull, Dinesh K.
    INFLAMMOPHARMACOLOGY, 2017, 25 (03) : 277 - 292
  • [4] Potential drug targets and treatment of schizophrenia
    Anil Kumar
    Monu Yadav
    Milind Parle
    Sameer Dhingra
    Dinesh K. Dhull
    Inflammopharmacology, 2017, 25 : 277 - 292
  • [5] A new drug for the treatment of schizophrenia
    Lynn, Shari J.
    AMERICAN JOURNAL OF NURSING, 2007, 107 (05) : 30 - 30
  • [7] Iloperidone: A new drug for the treatment of schizophrenia
    Arif, Sally A.
    Mitchell, Melissa M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (04) : 301 - 308
  • [9] Anthranilic Acid - A Potential Biomarker and Treatment Target for Schizophrenia
    Oxenkrug, Gregory
    Summergrad, Paul
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S219 - S219
  • [10] Cannabidiol's role as a potential target in the treatment for schizophrenia
    Carvalho, A.
    Felgueiras, J.
    Abreu, T.
    Freitas, C.
    Silva, J.
    EUROPEAN PSYCHIATRY, 2017, 41 : S631 - S631